3 Things You'll Want to Closely Watch in CVS Health's Q3 Results
When CVS Health (NYSE: CVS) reported its second-quarter results in August, there were two main stories -- one good, and one not so good. The good news stemmed from its pharmacy services segment, which consists of the CVS Caremark pharmacy benefits management (PBM) unit along with several other businesses. Results from CVS Health's retail/long-term care (LTC) segment, though, were lackluster.
Will it be the same two stories when CVS Health provides a third-quarter update on Nov. 6? Here are three things you'll want to closely watch.
Image source: Getty Images.
Source: Fool.com
CVS Health Corp. Aktie
51,77 €
0,60 %
Überwältigendes Buy-Interesse für CVS Health Corp.: 23 Buy-Einschätzungen ohne eine einzige Sell-Einschätzung.
Bei einem Kursziel von 79 € für CVS Health Corp. deutet sich eine Steigerung von über 50% vom aktuellen Kurs von 51.77 € an.
